The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Top Cited Papers
Open Access
- 18 April 2016
- journal article
- review article
- Published by Elsevier BV in EBioMedicine
- Vol. 6, 42-49
- https://doi.org/10.1016/j.ebiom.2016.03.035
Abstract
No abstract availableKeywords
Funding Information
- Mitchell Center for Neurodegenerative Diseases
- John Sealy Memorial Fund
This publication has 89 references indexed in Scilit:
- Depletion of microglia and inhibition of exosome synthesis halt tau propagationNature Neuroscience, 2015
- Combination therapies: The next logical Step for the treatment of synucleinopathies?Movement Disorders, 2015
- 2015 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2015
- Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damageNeurobiology of Aging, 2014
- Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanismProceedings of the National Academy of Sciences of the United States of America, 2013
- Systemic vaccination with anti‐oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg‐AD miceJournal of Neurochemistry, 2013
- Oligomeric amyloid-β(1–42) induces THP-1 human monocyte adhesion and maturationBrain Research, 2009
- Distinct Early Folding and Aggregation Properties of Alzheimer Amyloid-β Peptides Aβ40 and Aβ42Online Journal of Public Health Informatics, 2006
- Common mechanisms of amyloid oligomer pathogenesis in degenerative diseaseNeurobiology of Aging, 2006
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996